Cargando…

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

PURPOSE: Glioma is the most prevalent malignant form of brain tumors, with a dismal prognosis. Currently, cancer immunotherapy has emerged as a revolutionary treatment for patients with advanced highly aggressive therapy-resistant tumors. However, there is no effective biomarker to reflect the respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Houshi, Zhu, Qingwei, Tang, Lan, Jiang, Junkun, Yuan, Huiwen, Zhang, Anke, Lou, Meiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881595/ https://www.ncbi.nlm.nih.gov/pubmed/33579299 http://dx.doi.org/10.1186/s12935-021-01804-3

Ejemplares similares

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
por: Xu, Houshi, et al.
Publicado: (2022)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

Cytotoxic FCER1G(+) innate-like T cells: new potential for tumour immunotherapy
por: Morrish, Emma, et al.
Publicado: (2022)

Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi‐center study
por: Zhang, Anke, et al.
Publicado: (2021)

FCER1G Gene Hypomethylation in Patients with Rheumatoid Arthritis
por: Podgórska, Dominika, et al.
Publicado: (2022)

Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
por: Fu, Lin, et al.
Publicado: (2020)

Targeting parvalbumin promotes M2 macrophage polarization and energy expenditure in mice
por: Lin, Shaojian, et al.
Publicado: (2022)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022)

TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma
por: Fang, Chaoyou, et al.
Publicado: (2022)

Prognostic role of METTL1 in glioma
por: Li, Lun, et al.
Publicado: (2021)

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
por: Chai, Rui-Chao, et al.
Publicado: (2019)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration
por: Li, Jiahua, et al.
Publicado: (2022)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
por: Wang, Hui, et al.
Publicado: (2020)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma
por: Chen, Liang, et al.
Publicado: (2017)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease
por: Liu, Shanshan, et al.
Publicado: (2020)

The functions and prognostic value of Krüppel‐like factors in breast cancer
por: Zhu, Ke-Yun, et al.
Publicado: (2022)

Prognostic value and biological function of LRRN4 in colorectal cancer
por: Xu, Cheng, et al.
Publicado: (2022)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

IFNG, FCER1A, PCDHB10 expression as a new potential marker of efficacy in grass pollen allergen-specific immunotherapy
por: Romantowski, Jan, et al.
Publicado: (2021)

Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer
por: Liu, Chao, et al.
Publicado: (2019)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
por: Lin, Yilin, et al.
Publicado: (2021)

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma
por: Li, Si-wei, et al.
Publicado: (2016)

Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population
por: Xia, Rong, et al.
Publicado: (2021)

A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients
por: Yang, Jing, et al.
Publicado: (2020)

FCER2 T2206C variant associated with FENO levels in asthmatic children using inhaled corticosteroids: The PACMAN study
por: Karimi, Leila, et al.
Publicado: (2019)

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM
por: Bashore, Frances M., et al.
Publicado: (2023)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a1ch76d8jkjjulguem2ci0kp39